xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200027.xml | 200027 | 2025-11-06-08:00 | 7532675 | 1,995 | The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. | The Journal of experimental medicine | B Rehermann; P Fowler; J Sidney; J Person; A Redeker; M Brown; B Moss; A Sette; F V Chisari | 21144 | HBV Pol 455-462 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLSRYVAR | 8 | null | 453 | 460 | 10407 | AAD16253.1 | null | Exact Epitope | Not determined | TCell | 1350536 | 67 | Figure 5 | Negative | false | null | 9606 | null | null | DOID:2043 | 235 | null | T cell | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 7 |
200027.xml | 200027 | 2025-11-06-08:00 | 7532675 | 1,995 | The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. | The Journal of experimental medicine | B Rehermann; P Fowler; J Sidney; J Person; A Redeker; M Brown; B Moss; A Sette; F V Chisari | 21144 | HBV Pol 455-462 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLSRYVAR | 8 | null | 453 | 460 | 10407 | AAD16253.1 | null | Exact Epitope | Not determined | MhcBinding | 1350537 | 417 | Table 1 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13572 | MBP p85-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENPVVHFFKNIVTPR | 15 | null | 217 | 231 | 9606 | P02686.3 | null | Exact Epitope | Representative selection | TCell | 1660625 | 77 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13572 | MBP p85-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENPVVHFFKNIVTPR | 15 | null | 217 | 231 | 9606 | P02686.3 | null | Exact Epitope | Representative selection | TCell | 1660609 | 69 | Table 1 and Figure 1 | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13572 | MBP p85-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENPVVHFFKNIVTPR | 15 | null | 217 | 231 | 9606 | P02686.3 | null | Exact Epitope | Representative selection | TCell | 1660616 | 78 | Figures 2c, 3, 4 and 5 | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13572 | MBP p85-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENPVVHFFKNIVTPR | 15 | null | 217 | 231 | 9606 | P02686.3 | null | Exact Epitope | Representative selection | TCell | 1660619 | 171 | Figures 3, 4 and 5 | Negative | false | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13572 | MBP p85-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENPVVHFFKNIVTPR | 15 | null | 217 | 231 | 9606 | P02686.3 | null | Exact Epitope | Representative selection | TCell | 1660627 | 73 | Figures 4 and 5 | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13572 | MBP p85-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENPVVHFFKNIVTPR | 15 | null | 217 | 231 | 9606 | P02686.3 | null | Exact Epitope | Representative selection | TCell | 1660626 | 150 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 1 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13572 | MBP p85-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENPVVHFFKNIVTPR | 15 | null | 217 | 231 | 9606 | P02686.3 | null | Exact Epitope | Representative selection | MhcBinding | 201230 | 1 | Table 1 | Positive-High | true | 4.1 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13562 | MBP p85-99 89K analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVKHFFKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1660599 | 1 | Table 1 | Positive-Intermediate | true | 404.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13563 | MBP p85-99 90A analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVAFFKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1661594 | 196 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 6 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13563 | MBP p85-99 90A analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVAFFKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1660601 | 1 | Table 1 | Positive-High | true | 5.2 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13564 | MBP p85-99 90D analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVDFFKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1661598 | 196 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 5 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13564 | MBP p85-99 90D analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVDFFKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1660602 | 1 | Table 1 | Positive-Intermediate | true | 76.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13574 | MBP p85-99 90K analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVKFFKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1660605 | 1 | Table 1 | Positive-High | true | 7.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13565 | MBP p85-99 91A analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVHAFKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1660606 | 1 | Table 1 | Positive-High | true | 2.1 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13566 | MBP p85-99 92A analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVHFAKNIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1660607 | 1 | Table 1 | Positive-Intermediate | true | 283.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200028.xml | 200028 | 2025-11-06-08:00 | 7536622 | 1,995 | Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. | Immunity | A Windhagen; C Scholz; P Höllsberg; H Fukaura; A Sette; D A Hafler | 13567 | MBP p85-99 93A analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ENPVVHFFANIVTPR | 15 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 1660608 | 1 | Table 1 | Positive-High | true | 3.5 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 88 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AADKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201234 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 88 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AADKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201232 | 1 | Table 2 | Positive-High | true | 50.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 88 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AADKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201233 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 88 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AADKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201236 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 88 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AADKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201235 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2361 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201238 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2361 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201237 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2361 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201239 | 1 | Table 2 | Positive-Intermediate | true | 85.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2361 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201240 | 1 | Table 2 | Positive-High | true | 33.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2361 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201241 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201242 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201244 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201243 | 1 | Table 2 | Positive-Intermediate | true | 125.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201246 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2404 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201245 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 2892 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALSRKVAEL | 9 | null | 108 | 116 | 9606 | P43357.1 | null | Exact Epitope | Not determined | MhcBinding | 201247 | 1 | Table 8 | Positive-Intermediate | true | 100.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4859 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201248 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4859 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201249 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4859 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201250 | 1 | Table 2 | Positive-Intermediate | true | 59.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4859 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201251 | 1 | Table 2 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4859 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAAAAAAK | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201252 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4881 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201253 | 1 | Table 2 | Positive-High | true | 15.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4881 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201257 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4881 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201255 | 1 | Table 2 | Positive-Intermediate | true | 329.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4881 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201256 | 1 | Table 2 | Positive-Intermediate | true | 77.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4881 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201254 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4922 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATDKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201258 | 1 | Table 2 | Positive-High | true | 3.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4922 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATDKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201260 | 417 | Table 2 | Positive-Low | true | 9250.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4922 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATDKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201262 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4922 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATDKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201259 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 4922 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATDKAAAAY | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201261 | 1 | Table 2 | Positive-Low | true | 840.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 5724 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AYAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201264 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 5724 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AYAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201266 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 5724 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AYAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201263 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 5724 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AYAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201267 | 1 | Table 2 | Positive-Intermediate | true | 115.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 5724 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AYAKAAAAF | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201265 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 6631 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | CLTFGRETV | 9 | null | 135 | 143 | 10407 | P24023.1 | null | Exact Epitope | Not determined | MhcBinding | 201268 | 417 | Table 5 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 9084 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLFGIWSKV | 9 | null | 201 | 209 | 9606 | P15309.3 | null | Exact Epitope | Not determined | MhcBinding | 201270 | 417 | Table 8 | Negative | false | 25000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 9254 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLQQSLRVL | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201271 | 417 | Table 8 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 9318 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLVHFASPL | 9 | null | 817 | 825 | 10407 | CAA46352.1 | null | Exact Epitope | Not determined | MhcBinding | 201272 | 417 | Table 8 | Negative | false | 16667.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 9329 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLVVSYVNV | 9 | null | 112 | 120 | 10407 | AAR03807.1 | null | Exact Epitope | Not determined | MhcBinding | 201273 | 417 | Table 8 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 13087 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELHPDKWTV | 9 | null | 233 | 241 | 11676 | 2IAJ_A | null | Exact Epitope | Not determined | MhcBinding | 201274 | 417 | Table 5 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 13249 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRHYSDSV | 9 | null | 77 | 85 | 333761 | P06463.1 | null | Exact Epitope | Not determined | MhcBinding | 201275 | 417 | Table 5 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 16536 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLCKQYLNL | 9 | null | 665 | 673 | 10407 | P24024.1 | null | Exact Epitope | Not determined | MhcBinding | 201276 | 1 | Table 8 | Positive-High | true | 29.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 16618 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLGGTTVCL | 9 | null | 204 | 212 | 10407 | P24025.3 | null | Exact Epitope | Not determined | MhcBinding | 201277 | 1 | Table 8 | Positive-High | true | 29.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 16751 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLLSLGIHL | 9 | null | 573 | 581 | 10407 | P12933.1 | null | Exact Epitope | Not determined | MhcBinding | 201278 | 1 | Table 10 | Positive-Intermediate | true | 107.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 21098 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLRDLAVAV | 9 | null | 963 | 971 | 3052230 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 201279 | 417 | Table 5 | Positive-Low | true | 1470.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 21145 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLSRYVARL | 9 | null | 442 | 450 | 10407 | P24024.1 | null | Exact Epitope | Not determined | MhcBinding | 201280 | 1 | Table 8 | Positive-High | true | 42.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 24193 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | HLEGKVILV | 9 | null | 1,220 | 1,228 | 11676 | P05961.3 | null | Exact Epitope | Not determined | MhcBinding | 201282 | 417 | Table 5 | Positive-Low | true | 8333.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 24196 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | HLESLFTAV | 9 | null | 551 | 559 | 10407 | P24024.1 | null | Exact Epitope | Not determined | MhcBinding | 201283 | 417 | Table 8 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 24251 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | HLLVGSSGL | 9 | null | 446 | 454 | 10407 | P12933.1 | null | Exact Epitope | Not determined | MhcBinding | 201284 | 417 | Table 10 | Negative | false | 31000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 24302 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | HLSLRGLPV | 9 | null | 52 | 60 | 10407 | P24026.1 | null | Exact Epitope | Not determined | MhcBinding | 201285 | 417 | Table 5 | Negative | false | 12500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 24327 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | HLYSHPIIL | 9 | null | 502 | 510 | 10407 | P12933.1 | null | Exact Epitope | Not determined | MhcBinding | 201287 | 1 | Table 10 | Positive-Intermediate | true | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 27125 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILKEPVHGV | 9 | null | 902 | 910 | 11676 | P05961.3 | null | Exact Epitope | Not determined | MhcBinding | 201288 | 1 | Table 5 | Positive-Low | true | 909.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 37143 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLDDEAGPL | 9 | null | 13 | 21 | 10407 | P12933.1 | null | Exact Epitope | Not determined | MhcBinding | 201289 | 417 | Table 10 | Negative | false | 280000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 37364 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLGRNSFEV | 9 | null | 264 | 272 | 9606 | P04637.4 | null | Exact Epitope | Not determined | MhcBinding | 201290 | 1 | Table 5 | Positive-Intermediate | true | 357.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 37822 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLSSNLSWL | 9 | null | 418 | 426 | 10407 | P12933.1 | null | Exact Epitope | Not determined | MhcBinding | 201291 | 417 | Table 10 | Negative | false | 12100.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 37945 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLWKGEGAV | 9 | null | 1,394 | 1,402 | 11676 | P05961.3 | null | Exact Epitope | Not determined | MhcBinding | 201292 | 1 | Table 5 | Positive-Intermediate | true | 217.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 44892 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NLSWLSLDV | 9 | null | 422 | 430 | 10407 | P12933.1 | null | Exact Epitope | Not determined | MhcBinding | 201294 | 417 | Table 10 | Positive-Low | true | 4300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 44979 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NMGLKFRQL | 9 | null | 120 | 128 | 10407 | P24023.1 | null | Exact Epitope | Not determined | MhcBinding | 201295 | 417 | Table 8 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 48310 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PLERFAELV | 9 | null | 352 | 360 | 9606 | P15309.3 | null | Exact Epitope | Not determined | MhcBinding | 201299 | 417 | Table 8 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 48514 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PLTSIISAV | 9 | null | 650 | 658 | 9606 | P04626.1 | null | Exact Epitope | Not determined | MhcBinding | 201300 | 417 | Table 5 | Positive-Low | true | 3333.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 54496 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLCVQSTHV | 9 | null | 66 | 74 | 333760 | P03129 | null | Exact Epitope | Not determined | MhcBinding | 201301 | 417 | Table 5 | Negative | false | 16666.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 54774 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLSSNSRIL | 9 | null | 449 | 457 | 10407 | P03156.1 | null | Exact Epitope | Not determined | MhcBinding | 201302 | 417 | Table 8 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 54964 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | RMYSPISIL | 9 | null | 275 | 283 | 11676 | P05890.3 | null | Exact Epitope | Not determined | MhcBinding | 201303 | 1 | Table 8 | Positive-Intermediate | true | 56.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 59585 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLYADSPSV | 9 | null | 803 | 811 | 10407 | P24024.1 | null | Exact Epitope | Not determined | MhcBinding | 201305 | 1 | Table 8 | Positive-High | true | 14.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 72753 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | WLLRGTSFV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 201308 | 417 | Table 10 | Positive-Low | true | 3100.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 72794 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | WLSLLVPFV | 9 | null | 335 | 343 | 10407 | P24025.3 | null | Exact Epitope | Not determined | MhcBinding | 201309 | 1 | Table 5 | Positive-High | true | 6.9 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 74961 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 3052230 | P26662.3 | null | Exact Epitope | Not determined | MhcBinding | 201310 | 1 | Table 5 | Positive-High | true | 45.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 74988 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVTRHADV | 9 | null | 1,131 | 1,139 | 3052230 | P29846.3 | null | Exact Epitope | Not determined | MhcBinding | 201311 | 1 | Table 5 | Positive-Intermediate | true | 454.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200029.xml | 200029 | 2025-10-23-07:00 | 7536628 | 1,995 | Class I MHC-peptide interactions: structural requirements and functional implications. | Cancer surveys. | H M Grey; J Ruppert; A Vitiello; J Sidney; W M Kast; R T Kubo; A Sette | 59445 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLRVLAAGL | 9 | null | null | null | 9606 | null | null | Exact Epitope | null | MhcBinding | 22330195 | 417 | Table 8 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 909 | p230-249 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AEFQMTFHLFIAAFVGAAAT | 20 | null | 231 | 250 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201325 | 1 | Table 4 | Positive-High | true | 510.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 909 | p230-249 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AEFQMTFHLFIAAFVGAAAT | 20 | null | 231 | 250 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201324 | 1 | Table 4 | Positive-Low | true | 85000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 4970 | p20-39 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGLCFFGVALFCGCGHEAL | 20 | null | 21 | 40 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1687448 | 69 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:2377 | 368 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 7 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 4970 | p20-39 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGLCFFGVALFCGCGHEAL | 20 | null | 21 | 40 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201327 | 1 | Table 5 | Positive-Intermediate | true | 2700.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 4970 | p20-39 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGLCFFGVALFCGCGHEAL | 20 | null | 21 | 40 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201332 | 1 | Tables 4 and 5 | Positive-Low | true | 26000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 4970 | p20-39 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGLCFFGVALFCGCGHEAL | 20 | null | 21 | 40 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201331 | 1 | Table 5 | Positive-Low | true | 157000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 4970 | p20-39 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGLCFFGVALFCGCGHEAL | 20 | null | 21 | 40 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201330 | 417 | Table 5 | Negative | false | 250000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 4970 | p20-39 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGLCFFGVALFCGCGHEAL | 20 | null | 21 | 40 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201326 | 417 | Table 5 | Negative | false | 250000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 4970 | p20-39 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATGLCFFGVALFCGCGHEAL | 20 | null | 21 | 40 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 201328 | 417 | Tables 4 and 5 | Negative | false | 250000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 5516 | p170-189 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVPVYIYFNTWTTCQSIAFP | 20 | null | 171 | 190 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1687449 | 69 | Figure 4 and Table VI | Positive | true | null | 9606 | null | null | DOID:2377 | 436 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
200031.xml | 200031 | 2025-11-06-08:00 | 7541828 | 1,995 | T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Journal of immunology (Baltimore, Md. : 1950) | S Markovic-Plese; H Fukaura; J Zhang; A al-Sabbagh; S Southwood; A Sette; V K Kuchroo; D A Hafler | 5516 | p170-189 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVPVYIYFNTWTTCQSIAFP | 20 | null | 171 | 190 | 9606 | P60201.2 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1687450 | 69 | Figure 4 and Table VI | Positive | true | null | 9606 | null | null | DOID:2377 | 368 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.